Upadacitinib demonstrated long-term efficacy for the treatment of ankylosing spondylitis among patients who failed to respond ...
societal costs and cost-effectiveness as affected by sequential drug treatment strategies for ankylosing spondylitis (AS). Methods Discrete event simulation paradigm was selected for model development ...
case each of cerebrocardiovascular event and inflammatory bowel disease were reported in vunakizumab-treated (any exposure; n=538) patients; no treatment-emergent opportunistic infections, serious ...
Diseases of the joints are known as arthritis. The term is derived from the Greek word that means exactly that: diseases of ...
The term ankylosing spondylitis describes the process of bone fusion and subsequent typical ... The assessment of axial spondyloarthritis is relevant for understanding the disease status and effect, ...
It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis ... they preferred Cosentyx to previous treatments. Hughes said: “We have ...
The new criteria were formulated with the aim of enhancing design of clinical trials, and ultimately leading to earlier and more effective diagnosis and treatment in the clinical setting.
Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...
Women with axial spondyloarthritis face longer diagnostic delays and greater disease burden than men despite higher rates of ...
22, 2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically ...
Arthritis is a broad term that refers to the inflammation of joints resulting in joint pain, swelling, stiffness and limited ...
These treatments mainly focus on slowing down the progression of the disease and managing symptoms. Different people can have different types of MS, and disease progression and symptoms range ...